CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 174 enrolled
Drug / intervention
ACUVUE Oasys 1-Day with HydraLuxe Technology for Astigmatism +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05056870
NCT05056870N/ACompleted
CompareCT.gov

Clinical Evaluation of Spherical Soft Contact Lenses, Toric Soft Contact Lenses and Spectacles in Low Astigmats

Johnson & Johnson Vision Care, Inc.·interventional·Posted Sep 27, 2021·Updated Apr 27, 2023

In Brief

A clinical study evaluating ACUVUE Oasys 1-Day with HydraLuxe Technology for Astigmatism and ACUVUE Oasys 1-Day with HydraLuxe Technology for Visual Acuity. Completed, enrolled 174 participants across 13 sites.

Detailed Summary

This will be a 5-visit, randomized, partially single-masked, bilateral wear, dispensing, 2-treatment × 2-period crossover study with spectacle-wear washout and wash-in periods.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedSep 27, 2021
Enrollment StartSep 15, 2021
Primary CompletionMar 3, 2022
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 4.8 years ago

Interventions

ACUVUE Oasys 1-Day with HydraLuxe Technology for Astigmatismdevice

TEST

ACUVUE Oasys 1-Day with HydraLuxe Technologydevice

CONTROL